UCB SA - Company Profile

Powered by

All the data and insights you need on UCB SA in one report.

  • Save hours of research time and resources with
    our up-to-date UCB SA Strategy Report

  • Understand UCB SA position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

The following section provides information on UCB SA’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into UCB SA's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Jonathan Peacock

Chairman Executive Board Since: 2023 Age: 65

Mr. Jonathan Peacock has been the Chairman of the company since March 2023. He serves as a Director of the company since 2021. Prior to this he served as a Chairman from 2014- 2021 and Chief Executive Officer from 2014-2016 at Bellerophon Therapeutics, Inc. Previously he served as a Chairman of Arix Bioscience plc from 2016-2020.

Read Hide full bio of Jonathan Peacock

Fiona du Monceau

Vice Chairwoman Executive Board Since: 2022 Age: 45

Ms. Monceau has been the Vice Chairwoman of the company since 2023. She also served as the Interim Chairman of the company and GNCC. Prior to this, she served as a Chief Operating Officer of ExeVir Bio.

Read Hide full bio of Fiona du Monceau

Jean-Christophe Tellier

Chief Executive Officer Senior Management Since: 2014 Age: 64

Mr. Jean-Christophe Tellier has been the Chief Executive Officer of the company since 2014. Prior to this, he was the Executive Vice President of BioBrands and Solutions division of the company. Currently, he also serves as the Member of the Board of the European Federation of Pharmaceutical Industries and Associations (EFPIA), Vice Chairman of the Innovation Board Sponsored Committee (EFPIA), President of International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and Chairman of the BCR.

Read Hide full bio of Jean-Christophe Tellier

Sandrine Dufour

Chief Financial Officer; Executive Vice President Senior Management Since: 2020 Age: 57

Ms. Sandrine Dufour has been the Executive Vice President, and Chief Financial Officer of the company since July 2020. Prior to this role, she served as Chief Financial Officer at Proximus. Previously, she served as Executive Vice President of Innovation and Deputy Chief Financial Officer of Vivendi and Executive Vice President of Finance and Strategy at SFR.

Read Hide full bio of Sandrine Dufour

Iris Low-Friedrich, M.D.

Chief Medical Officer; Executive Vice President - Global Projects and Development Senior Management Since: 2008 Age: 62

Dr. Iris Low-Friedrich has been the Executive Vice President and the Chief Medical Officer of the company since 2008. Prior to this, she was the Head of Research and Development of Schwarz Pharma AG. Ms. Friedrich also served on the Executive Board of Schwarz Pharma AG, and Vice President and Head of Global Projects at BASF Pharma.

Read Hide full bio of Iris Low-Friedrich, M.D.
Gain a 360-degree view of UCB SA and make more informed decisions for your business Gain a 360-degree view of UCB SA and make more informed decisions for your business Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer